{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:17:53Z","timestamp":1785777473781,"version":"3.56.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"9","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":260,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation National Cancer Institute Cancer Center Support Grant","doi-asserted-by":"publisher","award":["P30 CA168524"],"award-info":[{"award-number":["P30 CA168524"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The inflammation-resolving and insulin-sensitizing properties of eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids have potential to augment effects of weight loss on breast cancer risk. In a feasibility study, 46 peri\/postmenopausal women at increased risk for breast cancer with a body mass index (BMI) of 28 kg\/m2 or greater were randomized to 3.25 g\/day combined EPA and DHA (\u03c9-3-FA) or placebo concomitantly with initiation of a weight-loss intervention. Forty-five women started the intervention. Study discontinuation for women randomized to \u03c9-3-FA and initiating the weight-loss intervention was 9% at 6 months and thus satisfied our main endpoint, which was feasibility. Between baseline and 6 months significant change (P &amp;lt; 0.05) was observed in 12 of 25 serum metabolic markers associated with breast cancer risk for women randomized to \u03c9-3-FA, but only four for those randomized to placebo. Weight loss (median of 10% for trial initiators and 12% for the 42 completing 6 months) had a significant impact on biomarker modulation. Median loss was similar for placebo (\u221211%) and \u03c9-3-FA (\u221213%). No significant change between \u03c9-3-FA and placebo was observed for individual biomarkers, likely due to sample size and effect of weight loss. Women randomized to \u03c9-3-FA exhibiting more than 10% weight loss at 6 months showed greatest biomarker improvement including 6- and 12-month serum adiponectin, insulin, omentin, and C-reactive protein (CRP), and 12-month tissue adiponectin. Given the importance of a favorable adipokine profile in countering the prooncogenic effects of obesity, further evaluation of high-dose \u03c9-3-FA during a weight-loss intervention in obese high-risk women should be considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prevention Relevance:<\/jats:title>\n                    <jats:p>This study examines biomarkers of response that may be modulated by omega-3 fatty acids when combined with a weight-loss intervention. While focused on obese, postmenopausal women at high risk for development of breast cancer, the findings are applicable to other cancers studied in clinical prevention trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1940-6207.capr-20-0656","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T15:20:13Z","timestamp":1625844013000},"page":"893-904","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Change in Blood and Benign Breast Biomarkers in Women Undergoing a Weight-Loss Intervention Randomized to High-Dose \u03c9-3 Fatty Acids versus Placebo"],"prefix":"10.1158","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8855-4133","authenticated-orcid":false,"given":"Carol J.","family":"Fabian","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-9979","authenticated-orcid":false,"given":"Christie A.","family":"Befort","sequence":"additional","affiliation":[{"name":"2Department of Population Health, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Phillips","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Nydegger","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Kreutzjans","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandy R.","family":"Powers","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Metheny","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Klemp","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Carlson","sequence":"additional","affiliation":[{"name":"3Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra K.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"3Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola M.","family":"Zalles","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Boca Raton Regional Hospital, Boca Raton, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-2831","authenticated-orcid":false,"given":"Erin D.","family":"Giles","sequence":"additional","affiliation":[{"name":"5Department of Nutrition, Agriculture and Life Sciences, Texas A&M University, College Station, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Hursting","sequence":"additional","affiliation":[{"name":"6Department of Nutrition and Nutrition Research Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Hu","sequence":"additional","affiliation":[{"name":"7Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-6964","authenticated-orcid":false,"given":"Bruce F.","family":"Kimler","sequence":"additional","affiliation":[{"name":"8Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"2022060817202166200_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10555-010-9252-1","article-title":"Obesity and breast cancer: status of leptin and adiponectin in pathological processes","volume":"29","author":"Grossmann","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"2022060817202166200_bib2","first-page":"107","article-title":"Circulating adipokines and inflammatory markers and postmenopausal breast cancer risk","volume":"16","author":"Gunter","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2022060817202166200_bib3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/ije\/dyu088","article-title":"Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis","volume":"43","author":"Macis","year":"2014","journal-title":"Int J Epidemiol"},{"key":"2022060817202166200_bib4","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/cancers7040883","article-title":"The interactions of obesity, inflammation and insulin resistance in breast cancer","volume":"7","author":"Rose","year":"2015","journal-title":"Cancers"},{"key":"2022060817202166200_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/obr.12377","article-title":"A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis","volume":"17","author":"Cabia","year":"2016","journal-title":"Obes Rev"},{"key":"2022060817202166200_bib6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1152\/physrev.00034.2017","article-title":"Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity","volume":"98","author":"Hammarstedt","year":"2018","journal-title":"Physiol Rev"},{"key":"2022060817202166200_bib7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1940-6207.CAPR-14-0334","article-title":"Leptin and adiponectin modulate the self-renewal of normal human breast epithelial stem cells","volume":"8","author":"Esper","year":"2015","journal-title":"Cancer Prev Res"},{"key":"2022060817202166200_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/nu11020454","article-title":"Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation","volume":"11","author":"Fr\u00fchbeck","year":"2019","journal-title":"Nutrients"},{"key":"2022060817202166200_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2005.05.047","article-title":"Serum adiponectin and leptin levels in Taiwanese breast cancer patients","volume":"237","author":"Chen","year":"2006","journal-title":"Cancer Lett"},{"key":"2022060817202166200_bib10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1158\/1940-6207.CAPR-16-0322","article-title":"Signals from the adipose microenvironment and the obesity-cancer link-a systematic review","volume":"10","author":"Himbert","year":"2017","journal-title":"Cancer Prev Res"},{"key":"2022060817202166200_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1940-6207.CAPR-11-0110","article-title":"Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer","volume":"4","author":"Morris","year":"2011","journal-title":"Cancer Prev Res"},{"key":"2022060817202166200_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cen.12086","article-title":"Sex hormone binding globulin and insulin resistance","volume":"78","author":"Wallace","year":"2013","journal-title":"Clin Endocrinol"},{"key":"2022060817202166200_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-013-2730-8","article-title":"Favorable modulation of benign breast tissue and serum risk biomarkers is associated with &gt;10% weight loss in postmenopausal women","volume":"142","author":"Fabian","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2022060817202166200_bib14","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.3390\/nu7075156","article-title":"Impact of weight loss on plasma leptin and adiponectin in overweight-to-obese post-menopausal breast cancer survivors","volume":"7","author":"Thompson","year":"2015","journal-title":"Nutrients"},{"key":"2022060817202166200_bib15","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/sj.ijo.0802437","article-title":"Intentional weight loss and incidence of obesity related cancers: the Iowa Women's Health Study","volume":"27","author":"Parker","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2022060817202166200_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.bjc.6602763","article-title":"Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC)","volume":"93","author":"Lahmann","year":"2005","journal-title":"Br J Cancer"},{"key":"2022060817202166200_bib17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/mnfr.201200445","article-title":"The inhibition of early stages of HER-2\/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs","volume":"57","author":"Yee","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"2022060817202166200_bib18","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1158\/0008-5472.CAN-11-0977","article-title":"Chemoprevention of breast cancer by fish oil in preclinical models: trials and tribulations","volume":"71","author":"Signori","year":"2011","journal-title":"Cancer Res"},{"key":"2022060817202166200_bib19","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/nu6114760","article-title":"n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer","volume":"6","author":"Monk","year":"2014","journal-title":"Nutrients"},{"key":"2022060817202166200_bib20","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1502522","article-title":"Signaling and immunoresolving actions of resolvin d1 in inflamed human visceral adipose tissue","volume":"197","author":"Titos","year":"2016","journal-title":"J Immunol"},{"key":"2022060817202166200_bib21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/jc.2006-1268","article-title":"Peroxisome proliferator-activated receptor \u03b3 and adipose tissue \u2014 understanding obesity-related changes in regulation of lipid and glucose metabolism","volume":"92","author":"Sharma","year":"2007","journal-title":"J Clin Endocrinol Metabol"},{"key":"2022060817202166200_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.11.004","article-title":"Fatty acids, eicosanoids and PPAR gamma","volume":"785","author":"Marion-Letellier","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"2022060817202166200_bib23","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/ATVBAHA.106.136853","article-title":"Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects","volume":"27","author":"Itoh","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022060817202166200_bib24","doi-asserted-by":"crossref","first-page":"e639972.1990","DOI":"10.1371\/journal.pone.0063997","article-title":"The eicosapentaenoic acid metabolite 15-deoxy-\u03b4(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPAR\u03b3-dependent mechanism","volume":"8","author":"Lefils-Lacourtablaise","year":"2013","journal-title":"PLoS One"},{"key":"2022060817202166200_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/cbt.26206","article-title":"Omega-3 polyunsaturated fatty acid promotes the inhibition of glycolytic enzymes and mTOR signaling by regulating the tumor suppressor LKB1","volume":"14","author":"Andrade-Vieira","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"2022060817202166200_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.plefa.2012.03.008","article-title":"Membrane lipid raft organization is uniquely modified by n-3 polyunsaturated fatty acids","volume":"88","author":"Turk","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2022060817202166200_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ijms19010028","article-title":"Docosahexaenoic acid in combination with dietary energy restriction for reducing the risk of obesity related breast cancer","volume":"19","author":"Manni","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2022060817202166200_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1158\/1940-6207.CAPR-15-0018","article-title":"Omega-3-acid ethyl esters block the pro-tumorigenic effects of obesity in mouse models of postmenopausal basal-like and claudin-low breast cancer","volume":"8","author":"Ford","year":"2015","journal-title":"Cancer Prev Res"},{"key":"2022060817202166200_bib29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/nu9121289","article-title":"Integrated immunomodulatory mechanisms through which long-chain n-3 polyunsaturated fatty acids attenuate obese adipose tissue dysfunction","volume":"9","author":"Liddle","year":"2017","journal-title":"Nutrients"},{"key":"2022060817202166200_bib30","doi-asserted-by":"crossref","first-page":"f3706","DOI":"10.1136\/bmj.f3706","article-title":"Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies","volume":"346","author":"Zheng","year":"2013","journal-title":"Br Med J"},{"key":"2022060817202166200_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13058-015-0571-6","article-title":"Omega-3 fatty acids for breast cancer prevention and survivorship","volume":"17","author":"Fabian","year":"2015","journal-title":"Breast Cancer Res"},{"key":"2022060817202166200_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.plefa.2009.05.011","article-title":"Dietary reference intakes for DHA and EPA","volume":"81","author":"Kris-Etherton","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2022060817202166200_bib33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/1940-6207.CAPR-14-0336","article-title":"Modulation of breast cancer risk biomarkers by high-dose omega-3 fatty acids: phase II pilot study in postmenopausal women","volume":"8","author":"Fabian","year":"2015","journal-title":"Cancer Prev Res"},{"key":"2022060817202166200_bib34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1158\/1055-9965.EPI-19-1572","article-title":"Effects of weight loss and weight regain on circulating biomarkers in overweight\/obese breast cancer survivors enrolled in a weight loss trial in the rural midwest","volume":"29","author":"Befort","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2022060817202166200_bib35","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ejcn.2013.197","article-title":"Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management","volume":"67","author":"Gray","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"2022060817202166200_bib36","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.jacc.2013.11.004","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"63","author":"Jensen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022060817202166200_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacl.2012.02.010","article-title":"Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load","volume":"6","author":"Derosa","year":"2012","journal-title":"J Clin Lipidol"},{"key":"2022060817202166200_bib38","doi-asserted-by":"crossref","first-page":"e7038","DOI":"10.1371\/journal.pone.0007038","article-title":"Dual energy X-ray absorptiometry body composition reference values from NHANES","volume":"4","author":"Kelly","year":"2009","journal-title":"PLoS One"},{"key":"2022060817202166200_bib39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1200\/JCO.2015.61.6375","article-title":"Randomized trial comparing telephone versus in-person weight loss counseling on body composition and circulating biomarkers in women treated for breast cancer: The Lifestyle, Exercise, and Nutrition (LEAN) study","volume":"34","author":"Harrigan","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022060817202166200_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2009.04.010","article-title":"Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women","volume":"58","author":"Varady","year":"2009","journal-title":"Metabolism"},{"key":"2022060817202166200_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1200\/JCO.2011.35.2237","article-title":"Prognostic effect of circulating adiponectin in a randomized 2 \u00d7 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer","volume":"30","author":"Macis","year":"2012","journal-title":"J Clin Oncol"},{"key":"2022060817202166200_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"2022060817202166200_bib43","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/db12-1042","article-title":"Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance","volume":"62","author":"Spencer","year":"2013","journal-title":"Diabetes"},{"key":"2022060817202166200_bib44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3945\/ajcn.116.148114","article-title":"Very-long-chain \u03c9-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial","volume":"105","author":"Hames","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"2022060817202166200_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1158\/1940-6207.CAPR-17-0354","article-title":"A randomized multicenter phase ii study of docosahexaenoic acid in patients with a history of breast cancer, premalignant lesions, or benign breast disease","volume":"11","author":"Gucalp","year":"2018","journal-title":"Cancer Prev Res"},{"key":"2022060817202166200_bib46","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-017-3936-7","article-title":"Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line","volume":"17","author":"Huang","year":"2017","journal-title":"BMC Cancer"},{"key":"2022060817202166200_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jnutbio.2019.05.007","article-title":"Dietary polyunsaturated fatty acids modulate adipose secretome and is associated with changes in mammary epithelial stem cell self-renewal","volume":"71","author":"Hill","year":"2019","journal-title":"J Nutr Biochem"},{"key":"2022060817202166200_bib48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1940-6207.CAPR-15-0235","article-title":"Influence of obesity on breast density reduction by omega-3 fatty acids: evidence from a randomized clinical trial","volume":"9","author":"Sandhu","year":"2016","journal-title":"Cancer Prev Res"},{"key":"2022060817202166200_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1811403","article-title":"Marine omega-3 fatty acids and prevention of vascular disease and cancer","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"key":"2022060817202166200_bib50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s12325-019-01211-1","article-title":"Critical differences between dietary supplement and prescription omega-3 fatty acids: a narrative review","volume":"37","author":"Hilleman","year":"2020","journal-title":"Adv Ther"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/14\/9\/893\/3100127\/893.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/14\/9\/893\/3100127\/893.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T16:53:27Z","timestamp":1725382407000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/14\/9\/893\/666758\/Change-in-Blood-and-Benign-Breast-Biomarkers-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,7,9]]},"published-print":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-20-0656","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22533145","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22533145.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6546961.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6546961","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]}}}